TDC
IMUC

Thompson Davis & Co’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Thompson Davis & Co’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-150
Closed -$7K – 1392
2014
Q2 		$7K Buy
+150
New +$7K 0.01% 567